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Introduction
Of the various types of formulation on the pharmaceutical market, solid oral forms (e.g. tablets, capsules) are the most common. These formulations have many advantages, such as dose accuracy and relatively high stability, and also offer possibilities for modifying the drug release Page 1 of 18 profile in order to delay or sustain a therapeutic effect. Their palatability, however, especially if they have a bitter taste, is also important in maintaining patient adherence and thereby allowing effective pharmacotherapy to be attained [1, 2] .
Even plain tablets may be associated with problems such as difficulty in swallowing, not only in pediatric or geriatric populations but also for handicapped or bedridden patients. This may be due to large tablets sticking to the throat mucosa, causing irritation of the pharyngeal region, coughing or choking. One way to eliminate such problems is the use of the orally disintegrating tablet (ODT) [3] [4] [5] [6] [7] . The most important advantages of the ODT are quick disintegration after contact with saliva in the mouth, facilitating swallowing, and ease of delivery, with no need for water to wash down the drug, thus increasing patient adherence.
As leading formulation of ODT, Zydis ® [8] , or WOWTAB (without water tablet) were developed and commercialized. Nowadays, many ODTs are available [9] [10] [11] [12] [13] , owing to various manufacturing technologies developed by many researchers [14] [15] [16] [17] [18] [19] [20] [21] . The developers of pediatric medicines particularly focus on issues of palatability, for compliance reason [22, 23] .
Mini-sized ODTs have now been developed [24, 25] and their usefulness recently evaluated.
ODTs are not only of particular benefit to patients with poor swallowing ability, but also to populations with busy lives, as they can be taken at any time and in any place. In some cases, however, palatability issues such as the bitterness or astringency of the active ingredient may decrease adherence, since the acute drug concentration reached in the oral cavity can be extremely high due to the immediate disintegration of the tablet in saliva. Therefore taste-masking technology must be involved in the design of ODT formulations if the active ingredient is very bitter or astringent. The oral disintegration time of an ODT is a critical factor determining its palatability, rapid disintegration in the oral cavity being an essential feature of ODTs.
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The quantitative evaluation of palatability is now an important component in the process of formulation development for various types of oral formulation, including liquids. Human sensation test is major method to evaluate palatability of oral formulations [26] [27] [28] [29] [30] . However the use of human volunteers for taste-testing requires the volunteers to be accurate and precise, while ethical issues may prevent human taste-testing of some active drugs, e.g. anti-neoplastics.
The use of an artificial taste sensor removes these difficulties. We have used the taste sensor to evaluate the bitterness of many kinds of medicines (both basic and acidic drugs) and have demonstrated its ability to predict accurately the bitterness intensity experienced by human senses . The sensor is now available worldwide.
Evaluation of taste including bitterness or astringency of medicines
1-1. Insent taste-sensing system
The first taste sensor, composed of lipid/polymer membrane was developed by Toko [53] , and is now marketed as the Insent taste-sensing system (Intelligent Sensor Technology Inc., Atsugi, Japan) [54] [55] [56] (Fig. 1) . The taste sensor output exhibits different patterns for chemical substances that have different taste qualities, i.e. bitterness, sourness, saltiness, umami and sweetness. We have previously evaluated the bitterness of various medicines and amino acids using this system and suggested that the sensor may be useful to predict quantitatively the bitterness of medicines [31] [32] [33] . Antibiotics including clarithromycin dry syrup, have been evaluated using this system and a good correlation was obtained between the results of human gustatory sensation testing and the predicted bitterness intensity calculated from the taste sensor output [34] . Aminoleban EN, an elemental diet containing a large quantity of branched chain amino acids (BCAAs) which have a bitter taste, was also successfully evaluated using this system [35, 36] . Kataoka et al. [39, 40] evaluated bottled nutritive drinks using this system and founded that the bitterness or sourness predicted by taste sensor output correlated well with the results obtained human sensation testing. Not only the taste of medicines but also the suppression of unpleasant tastes could be predicted by this this system. Tsuji et al. [41] , and Ishizaka et al. [42] reported on the bitterness-suppressing effect of the jellies using this system, while Tokuyama et al. [43] used it to demonstrated that L -Ornithine suppresses the bitterness of BCAA solutions. Hashimoto et al. [44] demonstrated a method for predicting the bitterness-suppressing effect of sweeteners on a famotidine formulation using the sweetness responsive sensor.
1-2. α-ASTREE electronic tongue
A quantitative taste sensor, the α-ASTREE electronic tongue (Alpha MOS, Toulouse, France) is able to evaluate the overall taste of product by using the output value from different electrodes [50] [51] [52] [57] [58] [59] [60] [61] [62] (Fig. 2) . This taste sensor consists of an array of seven liquid cross-sensitive electrodes or sensors based on the ChemFET technology (Chemical modified field effect transistor), an auto-sampler, and associated interface electronic module. In the presence of dissolved compounds, a potentiometric difference is measured between each of the seven sensors and the Ag/AgCl reference electrode. Each sensor has a specific organic membrane, which interacts with ionic, neutral and chemical compounds present in the sample solution. Any interaction at the membrane interface is detected by the sensor and converted into an electronic signal. The taste sensor output is used to calculate the Euclidian distance, a variable used to quantify the taste of the sample medium [57] . Tokuyama E et al [50] 
Evaluation of ODTs
2-1. Disintegration time
In Japanese pharmacopoeia (JP), ODTs are described as tablets that rapidly dissolve or disintegrate in the mouth. However, no definition of the disintegration time is given and no method is specified for measurement.
Three different pieces of apparatus for estimating disintegration time are marketed in Japan,
(1) ODT-101 (Toyama Sangyo Co., Ltd., Osaka), (2) TRI-CORPTESTER (Okada Seiko Co., Ltd., Tokyo) and (3) OD-mate (Higuchi Inc., Tokyo).
(1) ODT-101
The disintegration testing apparatus ODT-101 was developed by Narazaki and Harada et al. [45, [63] [64] [65] . An ODT sample is placed on a stainless plate. Weight is provided to the shaft which is capable of moving in the vertical direction and rotating, The liquid surface of the test medium (450 mL purified water) is automatically adjusted by a pump so that the water level is slightly below the lower face of the porous plate. The liquid temperature is set to 37℃. The ODT is sandwiched between the rotating weight and the stainless plate such that the load and shear force can be applied to the ODT. Simultaneously, the block is immersed in the test medium and the water level of the test medium increases. The ODT then absorbs the test medium by capillary suction, resulting in disintegration. The effects of load, shear, and wetting, reproduce the conditions in the oral cavity in which an ODT becomes wet with saliva and is lightly ground between the tongue and upper jaw.
The disintegration times of propiverine hydrochloride ODTs [45] , ambroxol tablets [66] were measured using the ODT-101 and the results showed good agreement with the results of human sensation tests.
(2) TRI-CORPTESTER
Hoashi et al. [67] developed a simple test apparatus to evaluate the disintegration time of rapidly disintegrating tablets (RDTs). This apparatus consists of a simple device, which provides a similar environment to that of the oral cavity, and has been commercialized by Okada Seiko
Co., Ltd. (Tokyo, Japan) as TRI-CORPTESTER. The device is composed of two meshes; a lower mesh, on which the ODT is placed, and an upper mesh, attached to holders, which is in contact with the ODT and on which artificial saliva is dripped from above. The disintegration time is measured as the time elapsed until the tablet completely disintegrates and the two meshes touch each other. Yoshita et al. [68] reported that the in vitro disintegration time of
ODTs measured using TRI-CORPTESTER is a good reflection of the disintegration time in the oral cavity. Matsui et al. [69] also used this method to confirm the disintegration time was within 30s, as recommended by the FDA. testing. This apparatus was also used for donepezil ODTs to evaluate disintegration time by
Hazekawa et al [72, 73] .
2-2 Combined taste sensor and apparatus to estimate disintegration time of ODTs
While human gustatory sensation testing is the major method for the in-vivo evaluation of palatability, this method is associated with difficulties and limitations, as mentioned above. A well-established statistical method is required to overcome errors and variability between volunteers within the limits of threshold taste perceptions. Pediatric formulations cannot be tested by pediatric volunteers for ethical reasons. Taste sensor systems which can predict human taste accurately are required as alternative methods for the evaluation of palatability.
Taste masking is almost always necessary for ODTs because most active pharmaceutical ingredients produce an unpleasant taste sensation, such as bitterness, when they dissolve in the oral cavity. Therefore, ODT formulations are required which disintegrate quickly but without expressing bitterness. The combination of taste-sensing system and an apparatus to estimate disintegration time to predict the palatability of ODTs has been reported in several papers. The combination of the Insent taste-sensing system and OD-mate was reported by Uchida et al. [71] and Yoshida et al. [49] , while Haraguchi et al. [52] reported a combination of the α-ASTREE electronic tongue and the OD-mate. Table 1 shows the list of evaluated ODTs using systems for estimating disintegration time and taste.
Conclusion
Woerts et al. [74] have conducted a comparative study of the Insent taste-sensing system and α-ASTREE electronic tongue for pharmaceutical formulations. Those authors reported that both systems have their merits and limitations. The Insent taste-sensing system, in which each taste sensor membrane responds to a particular taste, is highly skilled in the quantitative evaluation of taste, such as bitterness intensity. However, some substances are not detected by this system. On the other hand, α-ASTREE electronic tongue is particularly good at evaluating overall taste. It is also capable of qualitative evaluation by comparing Euclidean distances, representing the similarity of tastes. From our previous studies, solifenacine succinate has been evaluated by both Insent taste-sensing system and α-ASTREE electronic tongue [47] . However the taste sensor output produced by ebastine was too low for the bitterness of the formulations to be evaluated [52] .
Thus, although the combination of a taste-sensing system and an apparatus to estimate disintegration time would be useful for predicting the palatability of ODTs, we have to select the appropriate devices for combination based on the characteristics of the formulation and its ingredients. TRI-CORPTESTER [68] 
